David L. Alexander

Papers

Total Citations

H-Index

About

David L. Alexander is a bioprocess engineer and cell line development specialist whose research focuses on the rapid, high-yield production of complex therapeutic glycoproteins, particularly for HIV vaccine development. His most significant contribution is pioneering robotic selection systems to accelerate the creation of stable Chinese Hamster Ovary (CHO) cell lines, addressing a critical bottleneck: HIV envelope glycoproteins (Envs) are notoriously difficult to express, yielding 10-100 fold less than standard pharmaceutical proteins. By automating the screening and selection of high-producing clones, Alexander’s work dramatically shortens development timelines and improves titers, making scalable HIV vaccine manufacturing more feasible. His 2018 paper on this topic has garnered 21 citations, reflecting its importance in the bioprocessing community. Beyond HIV, his methods have broad implications for producing other challenging biologics. Alexander’s research bridges automation, cell engineering, and virology, offering practical solutions for industrial biotechnology. His work is essential reading for students and researchers interested in cell line engineering, vaccine manufacturing, and the application of robotics to bioprocess development.